Outbreak field responses run ahead of their own evidence.
Facing the world's second-largest Ebola outbreak with no licensed vaccine or treatment for the Bundibugyo strain, authorities vaccinate frontline workers with a mismatched Zaire-strain shot on hope of cross-protection while declaring the peak independent reviewers say the data do not confirm.
The same conclusion keeps arriving from across the workspace's research — 1 topics independently instantiate this theme. Filter the evidence by where it came from:
Field vaccination with a mismatched strain proceeds on antibody reactivity alone, running ahead of any neutralization or protection evidence while commentators warn of complacency.
Frontline workers are being dosed with a mismatched Zaire-strain vaccine at scale while cross-protection remains an emerging, trial-mediated hypothesis rather than strain-specific proof.